Tema Heart & Health ETF Rating $37.24 -0.20 (-0.53%) As of 02:08 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.78Holdings in HRTS have an aggregate rating of Moderate Buy based on 530 analyst ratings issued in the past year covering 22 companies (72.8% of the portfolio).HRTS Aggregate Price Target$37.24High Prediction$37.24Average Prediction$37.24Low Prediction$37.24Holdings in HRTS have an aggregate price target of $37.24 and a range of $37.24 to $37.24 covering 22 companies (72.8% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 HRTS Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.11%LLYEli Lilly and Company$1,179.81-2.4%4.732 of 5 stars2.83$1,292.18 9.5%30Trending NewsAnalyst DowngradeInsider TradeAnalyst Revision5.54%UNHUnitedHealth Group$402.24+0.8%4.9377 of 5 stars2.89$455.92 13.3%27Dividend Announcement4.56%TMOThermo Fisher Scientific$591.94-0.7%4.6535 of 5 stars2.79$619.41 4.6%24Insider Trade4.23%RHHBYRoche$54.52-1.7%3.952 of 5 stars2.36$60.00 10.1%11Analyst Revision4.10%MRKMerck & Co., Inc.$135.80+0.2%4.3446 of 5 stars2.68$135.50 -0.2%22Trending NewsAnalyst ForecastInsider TradeAnalyst Revision3.85%JNJJohnson & Johnson$261.04-0.4%4.8021 of 5 stars2.80$268.22 2.8%25Trending News3.37%RVMDRevolution Medicines$203.10+0.5%2.4215 of 5 stars2.91$161.79 -20.3%22Analyst Forecast3.18%CYTKCytokinetics$74.12+0.9%3.5587 of 5 stars2.86$102.20 37.9%21Analyst ForecastAnalyst Revision3.10%ABTAbbott Laboratories$111.17-0.1%4.6911 of 5 stars2.96$118.67 6.7%27Positive NewsAnalyst Upgrade2.89%GILDGilead Sciences$138.18+0.0%4.4525 of 5 stars2.83$158.04 14.4%29Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision2.84%DHRDanaher$203.28-0.3%4.4043 of 5 stars2.84$228.91 12.6%252.69%VRTXVertex Pharmaceuticals$505.83-2.1%4.4256 of 5 stars2.92$563.50 11.4%242.65%BBIOBridgeBio Pharma$79.81-1.7%3.5414 of 5 stars2.83$100.79 26.3%23Trending NewsEarnings ReportAnalyst Forecast2.56%ABBVAbbVie$250.00-0.3%4.9053 of 5 stars2.88$275.50 10.2%26Trending NewsAnalyst ForecastAnalyst Revision2.27%BMYBristol Myers Squibb$64.18-0.7%4.219 of 5 stars2.52$66.06 2.9%25Trending NewsAnalyst Revision2.23%ISRGIntuitive Surgical$397.75-0.9%4.6431 of 5 stars2.68$508.68 27.9%31Positive NewsAnalyst UpgradeInsider TradeGap Up2.09%MDTMedtronic$91.66+1.2%4.7211 of 5 stars2.67$98.83 7.8%27Positive NewsUpcoming EarningsOptions Volume2.04%AMGNAmgen$414.22-0.9%3.8123 of 5 stars2.35$372.39 -10.1%31Analyst ForecastInsider Trade1.96%REGNRegeneron Pharmaceuticals$805.630.0%3.78 of 5 stars2.62$793.74 -1.5%26Insider Trade1.91%TEVATeva Pharmaceutical Industries$36.65+0.3%4.1296 of 5 stars2.90$42.22 15.2%10Positive NewsAnalyst Forecast1.81%MCKMcKesson$868.74+1.4%4.9169 of 5 stars2.82$977.00 12.5%17Analyst ForecastInsider Trade1.79%DXCMDexCom$89.93-1.7%4.2125 of 5 stars2.89$88.71 -1.4%27Analyst Upgrade This page (NASDAQ:HRTS) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredWall Street is staring at the wrong AI tradeAnthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...The Oxford Club | SponsoredWhy I'm sending this one to my own familyBehind the Markets editor Kelly Maguire says she has never sent an email quite like this one. A sealed congres...Behind the Markets | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
